secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2023-10-20T23:59:59+00:00
Accession:  0001728117-23-000129
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio receives Nasdaq notice for non-compliance with $1.00 minimum bid price; 180-day cure period.
--------------------------------------------------------------------------------

- Nasdaq notified Gossamer Bio on Oct 19, 2023 that its common stock had a closing bid price below $1.00 for 30 consecutive business days.
- Company has until April 16, 2024 to regain compliance by maintaining at least $1.00 closing bid for 10 consecutive business days.
- If not compliant by deadline, Gossamer may transfer to Nasdaq Capital Market for an additional 180-day cure period.
- Company is evaluating options including a potential reverse stock split; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811723000129/0001728117-23-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811723000129/goss-20231019.htm
  HTML page:      https://secwatch.observer/filing/0001728117-23-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer